Ahmed Zaghloul – CEO, October Pharma, Egypt
Ahmed Zaghloul, CEO of October Pharma, stresses the need for better infrastructure for biosimilars in Egypt to stay competitive on a global level. He also highlights October Pharma’s ambitious export…
October Pharma (OP) S.A.E is an Egyptian enterprise molded by global aspirations. This has always demanded a preparedness and long- term organizational vision that can encompass the turbulence’s and paradoxes of shifting terms and terrain’s of business.
October Pharma (OP) is producing different pharmaceutical dosage forms of products under cGMP rules & regulations:
Solid (tablets, capsules & powder)
Liquid (syrup, drops, solution & spay)
Subcontract (Toll Out Manufacturing) for:
Soft Gelatin Capsules
Ampoule & Vial
Cream & Suppository
Powder
Contact
Piece #190, St. #25, 1st industrial zone,
6 October city. Cairo, Egypt
Tel: 38201832 / 38201652 / 38201329
Fax: +02 38201653
Email: info@octoberpharma.com
Ahmed Zaghloul, CEO of October Pharma, stresses the need for better infrastructure for biosimilars in Egypt to stay competitive on a global level. He also highlights October Pharma’s ambitious export…
“My primary concern is not the current economic situation, but rather the fact that there does not appear to be a clear vision for how Egypt can overcome these challenges…
Ayman El Deeb, cluster head of Astellas Egypt, highlights how the Egyptian affiliate of Astellas has been performing since its establishment five years ago. He also discusses the need for…
On Tuesday, February 12th, Pharmaboardroom attended a breakfast event hosted by the British Egyptian Business Association (BEBA) on competition law at the Cairo Semiramis Intercontinental Hotel. The theme for the…
Tarek Tawfik, managing director of AmCham Egypt, explains how Egypt’s latest economic reforms have transformed the country into an attractive destination for foreign investors. He highlights the special role of…
Nadia Lamloum, executive director of the British Egyptian Business Association (BEBA), discusses the role of her institution and the investment opportunities that Egypt has to offer, as well as the…
Dr Magdy Abdelhamid, president of the Egyptian Society of Cardiology, explains the main trends in cardiology in Egypt and the society’s prevention projects. He also gives insights into the latest…
Hassan Behnam, managing director of the French Chamber of Commerce and Industry in Egypt explains the investment opportunities Egypt has to offer, examines the close relationship between Egypt and France…
Last week saw the first meeting of the board of Egypt’s new Universal Healthcare Authority (UHA) managed by the Minister of Finance, Mohamed Maait. Created to oversee the implementation of…
Egypt continues to struggle with fake drugs reaching the hands of patients as the suppliers of counterfeit medicines become more sophisticated by adding company logos to packaging. The Egyptian police…
The Health Committee of the Egyptian House of Representatives is preparing to discuss a draft law from the government on the establishment of the “Egyptian Drug Authority.” The new…
Egypt has found a way to profit from the country’s access to cheap Hep C drugs by offering package holidays to tourists suffering from the disease, but the ‘tour and…
With the highest rate of Hepatitis C on the planet, Egypt is now making great efforts to eradicate the disease in the north MENA regions. Hep C is a disease…
As Egypt continues to grapple with the proliferation of the hepatitis C virus, fresh treatment, prevention and market access pathways are now being applied. Given the severity of Egypt’s hepatitis…
See our Cookie Privacy Policy Here
